Your browser doesn't support javascript.
loading
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study.
Adams, Charleen D; Richmond, Rebecca; Ferreira, Diana L Santos; Spiller, Wes; Tan, Vanessa; Zheng, Jie; Würtz, Peter; Donovan, Jenny; Hamdy, Freddie; Neal, David; Lane, J Athene; Smith, George Davey; Relton, Caroline; Eeles, Rosalind A; Haiman, Christopher A; Kote-Jarai, ZSofia; Schumacher, Fredrick R; Olama, Ali Amin Al; Benlloch, Sara; Muir, Kenneth; Berndt, Sonja I; Conti, David V; Wiklund, Fredrik; Chanock, Stephen J; Gapstur, Susan; Stevens, Victoria L; Tangen, Catherine M; Batra, Jyotsna; Clements, Judith A; Gronberg, Henrik; Pashayan, Nora; Schleutker, Johanna; Albanes, Demetrius; Wolk, Alicja; West, Catharine M L; Mucci, Lorelei A; Cancel-Tassin, Géraldine; Koutros, Stella; Sorensen, Karina Dalsgaard; Maehle, Lovise; Travis, Ruth C; Hamilton, Robert J; Ingles, Sue Ann; Rosenstein, Barry S; Lu, Yong-Jie; Giles, Graham G; Kibel, Adam S; Vega, Ana; Kogevinas, Manolis; Penney, Kathryn L.
Afiliación
  • Adams CD; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom. chaadams@coh.org.
  • Richmond R; University of Bristol, Bristol, United Kingdom.
  • Ferreira DLS; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.
  • Spiller W; University of Bristol, Bristol, United Kingdom.
  • Tan V; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.
  • Zheng J; University of Bristol, Bristol, United Kingdom.
  • Würtz P; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.
  • Donovan J; University of Bristol, Bristol, United Kingdom.
  • Hamdy F; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.
  • Neal D; University of Bristol, Bristol, United Kingdom.
  • Lane JA; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.
  • Smith GD; University of Bristol, Bristol, United Kingdom.
  • Relton C; Research Programs Unit, Diabetes and Obesity, University of Helsinki and Nightingale Health Ltd., Helsinki, Finland.
  • Eeles RA; University of Bristol, Bristol, United Kingdom.
  • Haiman CA; Nuffield Department of Surgical Sciences, University of Oxford and Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
  • Kote-Jarai Z; Nuffield Department of Surgical Sciences, University of Oxford and Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
  • Schumacher FR; University of Bristol, Bristol, United Kingdom.
  • Olama AAA; Bristol National Institute of Health Research Biomedical Research Centre, Bristol, United Kingdom.
  • Benlloch S; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.
  • Muir K; University of Bristol, Bristol, United Kingdom.
  • Berndt SI; Bristol National Institute of Health Research Biomedical Research Centre, Bristol, United Kingdom.
  • Conti DV; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.
  • Wiklund F; University of Bristol, Bristol, United Kingdom.
  • Chanock SJ; Bristol National Institute of Health Research Biomedical Research Centre, Bristol, United Kingdom.
  • Gapstur S; The Institute of Cancer Research, London, United Kingdom.
  • Stevens VL; Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Tangen CM; Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California.
  • Batra J; The Institute of Cancer Research, London, United Kingdom.
  • Clements JA; Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio.
  • Gronberg H; Seidman Cancer Center, University Hospitals, Cleveland, Ohio.
  • Pashayan N; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
  • Schleutker J; University of Cambridge, Department of Clinical Neurosciences, Cambridge, United Kingdom.
  • Albanes D; The Institute of Cancer Research, London, United Kingdom.
  • Wolk A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
  • West CML; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, United Kingdom.
  • Mucci LA; Warwick Medical School, University of Warwick, Coventry, United Kingdom.
  • Cancel-Tassin G; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
  • Koutros S; Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California.
  • Sorensen KD; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Maehle L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
  • Travis RC; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia.
  • Hamilton RJ; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia.
  • Ingles SA; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Rosenstein BS; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Lu YJ; Translational Research Institute, Brisbane, Queensland, Australia.
  • Giles GG; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Kibel AS; Translational Research Institute, Brisbane, Queensland, Australia.
  • Vega A; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Kogevinas M; University College London, Department of Applied Health Research, London, United Kingdom.
  • Penney KL; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Cambridge, United Kingdom.
Cancer Epidemiol Biomarkers Prev ; 28(1): 208-216, 2019 01.
Article en En | MEDLINE | ID: mdl-30352818
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Biomarcadores de Tumor / Metaboloma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Biomarcadores de Tumor / Metaboloma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido